e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Metsera, Inc. - Common Stock
(NQ:
MTSR
)
63.04
-0.69 (-1.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,249,241
Open
64.00
Bid (Size)
61.85 (20)
Ask (Size)
62.00 (1)
Prev. Close
63.73
Today's Range
62.48 - 64.33
52wk Range
12.30 - 66.10
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal
October 31, 2025
Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller company.
Via
Investor's Business Daily
Topics
Law Enforcement
Lawsuit
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
October 31, 2025
Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism.
Via
Stocktwits
Performance
YTD
+137.9%
+137.9%
1 Month
+21.0%
+21.0%
3 Month
+80.7%
+80.7%
6 Month
+145.8%
+145.8%
1 Year
+137.9%
+137.9%
More News
Read More
10 Health Care Stocks Whale Activity In Today's Session
October 30, 2025
Via
Benzinga
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
October 30, 2025
Via
Investor's Business Daily
Topics
Economy
Government
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
October 30, 2025
Via
Stocktwits
Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer
October 30, 2025
Via
Stocktwits
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
October 06, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session
October 30, 2025
Via
Benzinga
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
October 30, 2025
Via
Benzinga
The market is filled with gapping stocks in Thursday's session.
October 30, 2025
Via
Chartmill
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
October 30, 2025
Via
Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 30, 2025
Via
Benzinga
2 High-Yield Stocks With Fresh Catalysts
October 29, 2025
Via
The Motley Fool
Topics
Lawsuit
Google Parent Alphabet Has $754 Million Invested in These 3 Hot Growth Stocks. Here's the 1 Wall Street Likes the Most.
October 27, 2025
Via
The Motley Fool
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
October 25, 2025
Via
The Motley Fool
Topics
Government
Intellectual Property
World Trade
HALPER SADEH LLC ENCOURAGES MTSR, HOLX, MRUS SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
October 23, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Metsera Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR
October 23, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
2 Mega-Dividend Stocks With Yields As High As 7%
October 21, 2025
Via
The Motley Fool
Topics
Economy
Government
Intellectual Property
Down 44%, Should You Buy the Dip on Viking Therapeutics?
October 13, 2025
Via
The Motley Fool
Where Will Pfizer Be in 5 Years?
October 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
World Trade
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders
October 07, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
October 07, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Down 50%, Should You Buy the Dip on Pfizer?
October 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
3 Reasons to Buy Pfizer Stock Now
October 06, 2025
Via
The Motley Fool
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
October 03, 2025
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Metsera, Inc. - Common Stock publicly traded?
Yes, Metsera, Inc. - Common Stock is publicly traded.
What exchange does Metsera, Inc. - Common Stock trade on?
Metsera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metsera, Inc. - Common Stock?
The ticker symbol for Metsera, Inc. - Common Stock is MTSR on the Nasdaq Stock Market
What is the current price of Metsera, Inc. - Common Stock?
The current price of Metsera, Inc. - Common Stock is 63.04
When was Metsera, Inc. - Common Stock last traded?
The last trade of Metsera, Inc. - Common Stock was at 10/31/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert